Erythroid Atypical Chemokine Receptor 1 Deficiency Aggravates Immune-Mediated Kidney Disease
Authors:
- Katharina ArtingerKAKatharina Artinger
- Igor Novitzky-BassoINIgor Novitzky-Basso
- Konstantin A. KlötzerKKKonstantin A. Klötzer
- Corinna SchabhüttlCSCorinna Schabhüttl
- Julia Christine GutjahrJGJulia Christine Gutjahr
- Maryna SamusMSMaryna Samus
- Alexander H. KirschAKAlexander H. Kirsch
- Daniel LeitingerDLDaniel Leitinger
- Stefan WernitznigSWStefan Wernitznig
- Theophilus UmeizudikeTUTheophilus Umeizudike
Open Access
- 17 September 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (4) , 731-746
Abstract
Key Points: Selective erythroid atypical chemokine receptor 1 deficiency exacerbated disease activity in experimental GN via changes of the myeloid lineage. Activated monocytes and profibrogenic phenotypes of macrophages underlaid the kidney phenotype observed in erythroid-silent individuals. Genetically modified mouse models showed pathomechanisms of kidney diseases in patients of West African ancestry with erythroid atypical chemokine receptor 1 deficiency. Background: Single-nucleotide polymorphisms of the atypical chemokine receptor 1 ( ACKR1 ) gene encode human Duffy antigen blood groups. Most individuals of West African ancestry carry a single-nucleotide polymorphism in the promoter region of the ACKR1 gene that disrupts its transcription in erythroid cells but not in venular endothelial cells, leading to an erythroid-silent, FyBES Duffy phenotype. Methods: We used two mouse models of erythroid-selective ACKR1 deficiency to delineate the fundamental role of this receptor in the erythroid compartment in regulating the development of experimental immune-mediated kidney disease. Results: Humanized transgenic Duffy erythroid-silent Duffy-negative transgene mice and chimeric wild-type mice transplanted with ACKR1-deficient bone marrow, both selectively lacking erythroid ACKR1, showed increased disease activity and fibrosis after induction of nephrotoxic serum nephritis, as compared with their respective controls. Mice lacking erythroid ACKR1 exhibited altered serum chemokine levels and bone marrow monocytes displaying activated and promigratory phenotypes. Moreover, they showed an increase in kidney-infiltrating macrophages that were characterized by a profibrotic transcriptome signature. No changes in ACKR1 expression in kidney vascular endothelial cells were seen in erythroid ACKR1-deficient mice with or without nephrotoxic serum nephritis. Conclusions: Our data demonstrates that erythroid-specific ACKR1 deficiency led to an increased infiltration of the kidney by macrophages with an altered profibrotic phenotype in nephrotoxic serum nephritis, resulting in aggravated kidney disease.Keywords
Funding Information
- Austrian Science Fund (J4606)
- Medizinische Universität Graz (Vasc-Health Flagship)
- Welcome Trust Investigator Award (200817/Z/16/Z)
This publication has 75 references indexed in Scilit:
- Atypical chemokine receptors in cancerCytokine, 2024
- Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent mannerCell Reports, 2023
- Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenueAutoimmunity Reviews, 2022
- Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediatorsJHEP Reports, 2022
- The epidemiology of kidney disease in people of African ancestry with HIV in the UKeClinicalMedicine, 2021
- Comprehensive Integration of Single-Cell DataCell, 2019
- Bone marrow chimeras—a vital tool in basic and translational researchJournal of Molecular Medicine, 2019
- LAIR-1 activation inhibits inflammatory macrophage phenotype in vitroCellular Immunology, 2018
- Innate and adaptive immunity in experimental glomerulonephritis: a pathfinder talePediatric Nephrology, 2016
- The Duffy antigen receptor for chemokines: structural analysis and expression in the brainJournal of Leukocyte Biology, 1996